# US 2022/0017935 A1 · A Method for Enzymatic Resolution of Chiral Substances

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0017935 A1
- Document ID: US20220017935A1
- Status: Published application
- Kind: A1
- Application number: 17/311,835
- Filed: 2019-10-25
- Published: 2022-01-20
- Earliest claimed: 2018-12-10
- Assignees: South China University of Technology
- Applicants: South China University of Technology
- Inventors: Zhigang Li; Jinfen Su; Bo Yang; Yonghua Wang; Zhengcheng Li; Huayong Chen
- Web page: https://patentgrep.com/patent/US20220017935A1

## CPC

- C12P 41/001: {by metabolizing one of the enantiomers}
- C12N 9/20: Triglyceride splitting, e.g. by means of lipase
- C12P 7/04: acyclic
- C12P 7/22: aromatic
- C12P 7/40: containing a carboxyl group {including Peroxycarboxylic acids}
- C12P 7/42: Hydroxy-carboxylic acids
- C12P 7/62: Carboxylic acid esters
- C12P 41/004: {by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction}
- C12P 41/005: {by esterification of carboxylic acid groups in the enantiomers or the inverse reaction}
- C12P 13/02: Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)}
- C12Y 301/01003: Triacylglycerol lipase (3.1.1.3)
- C12Y 301/01074: Cutinase (3.1.1.74)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The invention belongs to the field of bioengineering and food technology, and discloses a method for enzymatic resolution of chiral substances, including the following steps: (1) preparing an enzyme solution with a lipase concentration of 1-3000 U/mL, and adding a soluble salt, a hydrophilic solvent and a hydrophobic solvent to the enzyme solution to form a three-liquid phase system; the hydrophobic solvent contains esters or amide compounds composed of racemic chiral compounds; (2) subjecting the three-liquid phase system to enzyme-catalyzed reaction under stirring condition; after the reaction is completed, standing or centrifuging the three-liquid phase system to divide it into three layers, which are a upper liquid layer, a middle liquid layer and a lower liquid layer from top to bottom. The optically pure chiral product after hydrolysis is mainly rich in the middle liquid layer or the lower liquid layer, while the upper liquid layer product is another ester or amide product containing an optically pure chiral product. The method has the advantages of low energy consumption, high raw material utilization rate, and mild reaction conditions, and solves the problems of low chiral resolution efficiency, poor chiral selectivity, low recovery rate, and difficulty in industrialization in the existing enzymatic method.

## Claims

### Claim 1

A method for enzymatic resolution of chiral substances, characterized in that it comprises the following steps:
(1) preparing an enzyme solution with a lipase concentration of 1-3000 U/mL, adding a soluble salt, a hydrophilic solvent and a hydrophobic solvent to the enzyme solution to form a three-liquid phase system; the mass ratios of the soluble salt, the hydrophilic solvent and the hydrophobic solvent to the enzyme solution are 0.1-0.9, 0.1-5 and 0.1-10, respectively; the hydrophobic solvent contains an ester or amide compound composed of a racemic chiral compound;
(2) subjecting the three-liquid phase system to enzyme-catalyzed reaction under stirring condition; after the reaction, standing or centrifuging the three-liquid phase system until it is divided into three layers, which are a upper liquid layer, a middle liquid layer and a lower liquid layer from top to bottom;
hydrolyzed optically pure chiral product is mainly concentrated in the middle liquid layer or the lower liquid layer, and the upper liquid layer product is another ester or amide product containing an optically pure chiral product.

### Claim 2 (depends on 1)

The method according to claim 1, characterized in that the hydrophilic solvent in step (1) is one or more of polyethylene glycol, polypropylene glycol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, ethylene glycol and acetone; or the hydrophilic solvent is one or more of [BMIM]Br, [BMIM]BF4, [EMIM]ETSO4 and [OMIM]Cl.

### Claim 3 (depends on 1)

The method according to claim 1, characterized in that the soluble salt in step (1) is one or more of sodium citrate, sodium chloride, ammonium sulfate, sodium carbonate, dipotassium hydrogen phosphate, potassium phosphate, potassium dihydrogen phosphate and dipotassium hydrogen phosphate.

### Claim 4 (depends on 1)

The method according to claim 1, characterized in that the hydrophobic solvent in step (1) is one or more of n-hexane, diethyl ether, isopropyl ether, ethyl acetate, cyclohexanol, petroleum ether, isooctane, benzene and toluene.

### Claim 5 (depends on 1)

The method according to claim 1, characterized in that the reaction conditions of step (2) are: a temperature of 30-45° C., and a reaction time of 20 min-4 h.

### Claim 6 (depends on 5)

The method according to claim 5, characterized in that the pH value of the three-liquid phase system in step (1) is 5-9.

### Claim 7 (depends on 6)

The method according to claim 6, characterized in that the lipase concentration in step (1) is 5-2000 U/mL.

### Claim 8 (depends on 7)

The method according to claim 7, characterized in that the mass ratios of the soluble salt, hydrophilic solvent and hydrophobic solvent to the enzyme solution are 0.2-0.8, 0.2-0.8 and 0.2-4, respectively.

### Claim 9 (depends on 1)

The method according to claim 1, characterized in that the ester or amide compound composed of the racemic chiral compound is one or more of racemic methyl mandelate, racemic Naproxen methyl ester, racemic (4-methoxy-phenyl)-1-ethanol acetate, racemic 1-(4-methoxyphenyl) ethanol acetate, and racemic 6-methyl-5-heptenyl-2-ol acetate.

### Claim 10 (depends on 1)

The method according to claim 1, characterized in that the ester or amide compound composed of the racemic chiral compound accounts for 0.1%-10% of the mass of the hydrophobic solvent, preferably 1%-5%.

### Claim 11 (depends on 2)

The method according to claim 2, characterized in that the reaction conditions of step (2) are: a temperature of 30-45° C., and a reaction time of 20 min-4 h.

### Claim 12 (depends on 3)

The method according to claim 3, characterized in that the reaction conditions of step (2) are: a temperature of 30-45° C., and a reaction time of 20 min-4 h.

### Claim 13 (depends on 4)

The method according to claim 4, characterized in that the reaction conditions of step (2) are: a temperature of 30-45° C., and a reaction time of 20 min-4 h.

### Claim 14 (depends on 2)

The method according to claim 2, characterized in that the ester or amide compound composed of the racemic chiral compound is one or more of racemic methyl mandelate, racemic Naproxen methyl ester, racemic (4-methoxy-phenyl)-1-ethanol acetate, racemic 1-(4-methoxyphenyl) ethanol acetate, and racemic 6-methyl-5-heptenyl-2-ol acetate.

### Claim 15 (depends on 3)

The method according to claim 3, characterized in that the ester or amide compound composed of the racemic chiral compound is one or more of racemic methyl mandelate, racemic Naproxen methyl ester, racemic (4-methoxy-phenyl)-1-ethanol acetate, racemic 1-(4-methoxyphenyl) ethanol acetate, and racemic 6-methyl-5-heptenyl-2-ol acetate.

### Claim 16 (depends on 4)

The method according to claim 4, characterized in that the ester or amide compound composed of the racemic chiral compound is one or more of racemic methyl mandelate, racemic Naproxen methyl ester, racemic (4-methoxy-phenyl)-1-ethanol acetate, racemic 1-(4-methoxyphenyl) ethanol acetate, and racemic 6-methyl-5-heptenyl-2-ol acetate.

### Claim 17 (depends on 2)

The method according to claim 2, characterized in that the ester or amide compound composed of the racemic chiral compound accounts for 0.1%-10% of the mass of the hydrophobic solvent, preferably 1%-5%.

### Claim 18 (depends on 3)

The method according to claim 3, characterized in that the ester or amide compound composed of the racemic chiral compound accounts for 0.1%-10% of the mass of the hydrophobic solvent, preferably 1%-5%.

### Claim 19 (depends on 4)

The method according to claim 4, characterized in that the ester or amide compound composed of the racemic chiral compound accounts for 0.1%-10% of the mass of the hydrophobic solvent, preferably 1%-5%.

### Claim 20 (depends on 11)

The method according to claim 11, characterized in that the pH value of the three-liquid phase system in step (1) is 5-9.
